Intra-Operative Adductor Canal Blocks
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Oct 28, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called "surgeon-administered adductor canal blocks" (sACB) during total knee arthroplasty (TKA) surgery. The goal is to see if this approach can effectively manage pain after surgery, help patients get moving more quickly, and potentially reduce their hospital stay. Traditionally, these blocks are given by an anesthesiologist before surgery, but this trial will compare that method with the new technique where the surgeon administers the block during the operation.
To participate in this study, you need to be at least 18 years old, scheduled for a primary TKA due to osteoarthritis, and able to provide informed consent. However, there are some reasons you might not be eligible, such as having certain allergies or health conditions, or if you have used specific pain medications recently. If you join the trial, you can expect to be part of a process that could help improve pain management for future knee surgery patients. Your involvement could contribute to valuable insights into the best practices for this type of surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male and female patients aged 18 years or older
- • 2. Primary TKA booked as SDD
- • 3. Diagnosis of osteoarthritis
- Exclusion Criteria:
- • 1. Inability or refusal to sign informed consent form
- • 2. Non-English or French speaking, and no licensed translator, family member or substitute decision maker available.
- • 3. Non-osteoarthritis primary diagnosis
- • 4. Allergy to analgesic medications
- • 5. Contraindication to spinal and/or regional anaesthesia
- • 6. Any use of opioid pain medication within four weeks of the index procedure(13)
- • 7. Pain catastrophizing scale score ≥16 (8, 9, 14)
- • 8. History of cirrhosis
- • 9. History renal insufficiency
- • 10. History or sensory and/or motor neuropathy to the ipsilateral limb
- • 11. Simultaneous, bilateral TKA
- • 12. Non-TKA prosthesis
- • 13. Scheduled for non-SDD TKA.
- • 14. Preoperative varus/valgus of \>10 degrees.
- • 15. Planned General Anaesthetic
- • 16. Use of Intrathecal Morphine
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Simon Garceau, MD
Principal Investigator
The Ottawa Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials